By BECKY UPHAM People without diabetes taking Wegovy (semaglutide) for weight loss were less likely to die of COVID-19 during the pandemic, a large new study found. Although the anti-obesity drug didn’t protect people from getting COVID-19, those on Wegovy were 33 percent less likely to die of the illness than those who took the…
This content is for 3 Months, 6 Months, and 12 Months members only.
Join Now
Join Now
Already a member? Log in here
